Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun An
antiviral drug for the treatment ofhepatitis B .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word clevudine.
Examples
-
The decrease in operating expenses for the quarter ended June 30, 2010 was primarily the result of discontinuing our clevudine program in
-
Eisai has licensed Stronger Neo-Minophagen C and Glycyron Tab. for the treatment of liver diseases and allergic diseases, and clevudine for the treatment of hepatitis B for marketing in Asian countries.
JCN Newswire 2009
-
Eisai has licensed Stronger Neo-Minophagen C and Glycyron Tab. for the treatment of liver diseases and allergic diseases, and clevudine for the treatment of hepatitis B for marketing in Asian countries.
JCN Newswire 2009
-
Eisai has licensed Stronger Neo-Minophagen C and Glycyron Tab. for the treatment of liver diseases and allergic diseases, and clevudine for the treatment of hepatitis B for marketing in Asian countries.
JCN Newswire 2009
-
Eisai has licensed Stronger Neo-Minophagen C and Glycyron Tab. for the treatment of liver diseases and allergic diseases, and clevudine for the treatment of hepatitis B for marketing in Asian countries.
JCN Newswire 2009
-
Eisai has licensed Stronger Neo-Minophagen C and Glycyron Tab. for the treatment of liver diseases and allergic diseases, and clevudine for the treatment of hepatitis B for marketing in Asian countries.
JCN Newswire 2009
-
Eisai has licensed Stronger Neo-Minophagen C and Glycyron Tab. for the treatment of liver diseases and allergic diseases, and clevudine for the treatment of hepatitis B for marketing in Asian countries.
JCN Newswire 2009
-
Eisai has licensed Stronger Neo-Minophagen C and Glycyron Tab. for the treatment of liver diseases and allergic diseases, and clevudine for the treatment of hepatitis B for marketing in Asian countries.
JCN Newswire 2009
-
Eisai has licensed Stronger Neo-Minophagen C and Glycyron Tab. for the treatment of liver diseases and allergic diseases, and clevudine for the treatment of hepatitis B for marketing in Asian countries.
JCN Newswire 2009
-
Eisai has licensed Stronger Neo-Minophagen C and Glycyron Tab. for the treatment of liver diseases and allergic diseases, and clevudine for the treatment of hepatitis B for marketing in Asian countries.
JCN Newswire 2009
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.